These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2807558)

  • 1. [Enoxacin concentrations in lung tissue].
    Adam D; Präuer H; Sörgel F; Zürcher J
    Infection; 1989; 17 Suppl 1():S21-2. PubMed ID: 2807558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enoxacin concentration in bone tissue].
    Adam D; Weismeier K; Sörgel F; Zürcher J
    Infection; 1989; 17 Suppl 1():S25-6. PubMed ID: 2807560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enoxacin concentrations in serum and in the wall of the colon during colorectal surgery].
    Wenzel M; Sörgel F; Muth P; Kraeft H
    Infection; 1989; 17 Suppl 1():S27-9. PubMed ID: 2807561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
    Morel C; Vergnaud M; Malbruny B; Benard Y
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of enoxacin into lung tissue.
    Newsom SW; Eden CG; Wells FC; Meredith P
    J Antimicrob Chemother; 1989 Jan; 23(1):113-5. PubMed ID: 2745246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin.
    Rogge MC; Solomon WR; Sedman AJ; Welling PG; Koup JR; Wagner JG
    Clin Pharmacol Ther; 1989 Oct; 46(4):420-8. PubMed ID: 2791445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
    Misiak PM; Eldon MA; Toothaker RD; Sedman AJ
    J Clin Pharmacol; 1993 Jan; 33(1):53-6. PubMed ID: 8429114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study.
    Desai KM; Abrams PH; White LO
    J Urol; 1988 Jun; 139(6):1232-4. PubMed ID: 2453683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of enoxacin in the treatment of prostatitis-vesiculitis: its absence of toxicity on spermatogenesis].
    Barletta D; Monzani F; Gasperi M; Caraccio N; Maccanti O; Bellitti P; Bonadio M; Pucci E
    Presse Med; 1995 Jun; 24(22):1025-7. PubMed ID: 7667229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
    Hamel B; Audran M; Costa P; Bressolle F
    J Chromatogr A; 1998 Jul; 812(1-2):369-79. PubMed ID: 9691332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.